Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study (Q46585156)
Jump to navigation
Jump to search
scientific article published on 5 July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study |
scientific article published on 5 July 2005 |
Statements
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study (English)
Evanthia Galanis
Bernd W Scheithauer
Jan C Buckner
Matthew J Maurer
Jeffrey I Kreisberg
Karla Ballman
J Boni
Josep M Peralba
Robert B Jenkins
Shaker R Dakhil
Roscoe F Morton
Kurt A Jaeckle
Janet Dancey
Daniel J Walsh
North Central Cancer Treatment Group
5 July 2005
23
23
5294-5304